Gastroparesis Market Set to Grow Strongly Through 2035 – BIS Research

What is Gastroparesis? 

Gastroparesis is a chronic condition characterized by delayed gastric emptying without mechanical obstruction. Common symptoms include nausea, vomiting, early satiety, bloating, and abdominal pain. The disorder can be idiopathic, diabetic, or postsurgical in origin. 

What is the Market Outlook? 

Technology Growth: 

• Transition from symptom-based therapy to targeted neuromodulation and gut motility modulation. 
• Advancements in gastric electrical stimulation (GES) devices and novel drug delivery systems for prokinetic agents. 

Regional Drivers: 

• North America: High diagnosis rates, favorable reimbursement in certain procedures, and robust pipeline of drug/device approvals. 
• Europe: Strong adoption of minimally invasive therapies and increasing clinical trial activity. 
• Asia-Pacific: Rapidly rising diabetes incidence in China and India driving higher prevalence of diabetic gastroparesis. 

Commercialization Push: 

• Pharmaceutical and medtech companies are actively pursuing FDA and EMA approvals for new motility drugs and next-gen gastric stimulators. 

How Fast is the Market Growing? 

The market is forecasted to grow at a healthy CAGR from 2025 to 2035, driven by both therapeutic and diagnostic segments. Growth will be strongest in emerging economies where diabetes rates are surging, and healthcare infrastructure is expanding. 

How Will This Report Help You? 

Planning to Enter the Market? 

• Identify country-level demand drivers such as diabetes prevalence, endoscopy capacity, and adoption of gastric stimulation devices. 

Analyzing the Competitive Landscape? 

• Evaluate established and emerging players in prokinetic drugs, gastric electrical stimulators, and motility diagnostic systems. 

Seeking R&D Insights? 

• Track innovations in neurostimulation, prokinetic drug formulations, wireless motility monitoring, and gut microbiome-targeted therapies. 

Interested in Regional Market Trends? 

• Access region-specific prevalence, diagnosis rates, and therapeutic adoption patterns for diabetic, idiopathic, and postsurgical gastroparesis. 

Download the Full TOC or Book a Preview 

What Technologies Are Transforming the Market? 

• Gastric Electrical Stimulation (GES): Implantable devices delivering electrical pulses to improve gastric motility. 
• Advanced Prokinetic Agents: Next-gen dopamine receptor modulators and ghrelin agonists. 
• Wireless Motility Capsules: Non-invasive diagnostics enabling precise gastric emptying assessment. 
• Targeted Microbiome Therapies: Experimental approaches modulating gut bacteria for improved motility. 

What’s Driving Demand, Opportunities, and Barriers?

Demand Drivers 

• Rising prevalence of diabetes worldwide. 
• Advances in motility diagnostic tools. 
• Growing patient awareness and access to specialty care. 

Opportunities 

• Expansion into underserved APAC and Middle East markets. 
• Development of combination therapies (drug + device). 
• Telehealth integration for long-term symptom management. 

Challenges 

• High cost of GES devices and limited reimbursement in many markets. 
• Slow drug development due to complex regulatory pathways. 
• Limited physician expertise in advanced gastroparesis management in emerging regions. 

Market Segmentation 

by Region 

•    North America 

•    Europe  

•    Asia-Pacific 

Strategic Developments 

• Increased clinical trials for novel prokinetic and neuromodulation therapies. 
• Strategic licensing agreements between pharma and medtech companies. 
• Growing partnerships with academic research centers for microbiome and motility studies. 

Download the complete TOC now! 

Case Study 

Pilot programs using GES in refractory diabetic gastroparesis patients in the U.S. showed notable symptom relief and improved gastric emptying rates, supporting broader adoption. 

Schedule a Call with Industry Experts  

Related Reports from BIS Research  

HER2+ Gastric Cancer Market 

Next-Generation Intervention Cardiology Market 

Flow Cytometry Market 

About BIS Research  

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.    

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.     

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.    

Contact  

Head of Marketing   

Email: media@bisresearch.com     

BIS Research Inc.    

39111 PASEO PADRE PKWY STE 313,    

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights    

Get Expert Insights @https://community.insightmonk.com     

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research     

Connect with us on Twitter@ https://twitter.com/BISResearch    

Connect with us on Medium@ https://medium.com/@faisal.bis  

Connect with us on youtube@ https://www.youtube.com/@BISResearchInc